We know little about the extent psychedelic substances are consumed therapeutically and/or discussed with medical professionals despite renewed global interest in these substances. We examined self-reported responses from the 2023 International Cannabis Policy Study (ICPS) in repeated cross-sectional surveys in Canada, the United States, Australia, and New Zealand. The survey included questions...
Preclinical and clinical studies reported that 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') can cause adverse effects in the central nervous system (CNS). Recently, preclinical studies have demonstrated that certain psychoactive substances may exacerbate the noxious central effects of MDMA when co-administered, including substances that are contained as adulterants in tablets sold as...
informed consent to psychedelic-assisted psychotherapy. Johnson, M. W. 2021. Consciousness, religion, and gurus: Pitfalls of psychedelic medicine. ACS Pharmacology & Translational Science 4 (2):578–81. doi:10.1021/acsptsci. 0c00198. Herzberg, G., K. Conour, J. Butler, A. Emerson, L. S. Gillooly, V. Gold, M. Hayes, L. Mix, and E. Sienknecht. 2019. Towards an ethos of equity and inclusion in the...